Top Trends Transforming the Lung Cancer Screening Market Landscape in 2025: Innovations In Artificial Intelligence (AI) Technology Enhance Early Detection And Diagnostic Precision In Chest Imaging

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Lung Cancer Screening Industry Market Size Be by 2025?
The market size for lung cancer screening has seen significant growth in the recent past. Its value is predicted to increase from $3.03 billion in 2024 to $3.33 billion in 2025, showing a compound annual growth rate (CAGR) of 9.9%. Several factors have contributed to this growth during the historical period including increased tobacco usage, heightened awareness about early detection of cancer, the implementation of government initiatives and screening programs, a rising aged population, and an increase in the presence of private diagnostic centers.

What's the Long-Term Growth Forecast for the Lung Cancer Screening Market Size Through 2029?
The market for lung cancer screening is forecasted to experience significant expansion in the coming years, with the projection suggesting growth to $4.79 billion in 2029, representing a compound annual growth rate (CAGR) of 9.5%. Factors contributing to the anticipated growth during the forecast period include the escalating effects of air pollution and occupational exposure, increasing evidence supporting the advantages of early screening, expansion of insurance coverage, urban population growth and changes in lifestyle, plus a surge in investment in radiology facilities. The forecast period also sees trends such as the emergence of cloud-based imaging platforms, breakthroughs in radiomics and image analysis, advancements in portable and point-of-care imaging technology, the incorporation of decision support systems within radiology routines, and progress in non-invasive biomarker-based screening.

View the full report here:
https://www.thebusinessresearchcompany.com/report/lung-cancer-screening-global-market-report

What Are the Key Growth Drivers Fueling the Lung Cancer Screening Market Expansion?
The escalating rates of smoking are predicted to fuel the expansion of the lung cancer screening market in the future. Smoking involves inhaling smoke from combusted materials, usually tobacco, into the mouth and lungs. The increment in smoking rates is attributed to rising stress levels, which prompt more individuals to use smoking as a stress relief. Lung cancer screening plays a significant role in tackling the growing smoking rates by facilitating the early identification of health dangers associated with smoking. This awareness can encourage people to stop smoking and contribute to wider public health objectives of reducing tobacco consumption. For instance, the Office for National Statistics, a government agency in the UK, reported in September 2023 that in Great Britain, around 4.5 million adults or 8.7% of the population had used e-cigarettes daily or occasionally in 2022. This marks a significant growth from 7.7% in 2021. Consequently, the growing smoking rates are propelling the expansion of the lung cancer screening market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27331&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Lung Cancer Screening Market?
Leading enterprises in the lung cancer screening market are concentrating on introducing sophisticated solutions, such as normal flagging. This is aimed at boosting diagnostic precision, curtailing false positives, and facilitating the early identification of cancerous nodules. Normal flagging is a technological aspect in lung cancer screening that spontaneously recognizes and alerts when scans do not reflect any unusual findings, aiding in prioritizing cases that require additional review. For example, in May 2025, Lunit Inc., a medical technology corporation based in South Korea, unveiled INSIGHT CXR4, its subsequent generation AI-powered chest X-ray examination solution, which is currently CE MDR-endorsed for use throughout Europe. Engineered to support radiologists with superior diagnostic precision and increased workflow efficiency, this solution can identify 12 chest irregularities, including lung nodules, pneumonia, and acute bone fractures, and offers features like current-prior image comparison to aid early disease detection and clinical decision-making.

How Is the Lung Cancer Screening Market Segmented?
The lung cancer screening market covered in this report is segmented

1) By Diagnosis Type: Low Dose Spiral Computed Tomography Scan, Chest-X-Ray
2) By Cancer Type: Non-Small Cell Lung Cancer, Small Cell Lung Cancer
3) By Age Group: 50 And Older, Below 50
4) By End-User: Hospitals And Clinics, Diagnostic Centers, Other End-Users

Subsegments:
1) By Low Dose Spiral Computed Tomography Scan: Screening, Diagnostic, Follow-Up
2) By Chest X-Ray: Posterior Anterior, Lateral, Portable

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=27331&type=smp

Which Companies Are Leading the Charge in Lung Cancer Screening Market Innovation?
Major companies operating in the lung cancer screening market are Johnson & Johnson Services Inc., F. Hoffmann-La Roche AG, AstraZeneca Plc, Abbott Laboratories Inc., Canon Inc., Medtronic Plc, Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare Technologies Inc., Quest Diagnostics Incorporated, Agilent Technologies Inc., Shimadzu Corporation, NeoGenomics Laboratories Inc., Freenome Holdings Inc., Biodesix Inc., Lunit Inc., Infervision, Riverain Technologies, VisionGate, and Delfi Diagnostics Inc.

Which Regions Are Leading the Global Lung Cancer Screening Market in Revenue?
North America was the largest region in the lung cancer screening market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lung cancer screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=27331

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.